Amylin expected to be the next big target Amylin analogs are a different modality (non-incretin) as it works by increasing satiety and increasing leptin sensitivity, which is a distinct mechanism compared to GLP-1
Its peptide-ceramide blend delivers hydration and anti-aging support in a single step
Whilst GLP-1 RA usage is effective at driving weight loss, the magnitude varies depending on factors such as the type of GLP-1 RA used, treatment duration, and the individual
SIBO-Rebuild addresses four of the most important post-SIBO repair targets simultaneously: (1) intestinal barrier integrity via L-Glutamine (enterocyte fuel) and Zinc (tight junction cofactor)
In rare cases, medications may trigger systemic inflammation, which may also affect the ocular surface and contribute to dry eye symptoms
It is structurally similar to glutamate, but the carboxylic acid group of the side chain is replaced by an amide